2021 Form 10-K Financial Statement
#000149315222007249 Filed on March 18, 2022
Income Statement
| Concept | 2021 | 2020 |
|---|---|---|
| Revenue | ||
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $585.5K | $760.1K |
| YoY Change | -22.97% | -69.59% |
| % of Gross Profit | ||
| Research & Development | $152.7K | $126.3K |
| YoY Change | 20.92% | -62.43% |
| % of Gross Profit | ||
| Depreciation & Amortization | $0.00 | $640.00 |
| YoY Change | -100.0% | -69.08% |
| % of Gross Profit | ||
| Operating Expenses | $738.2K | $887.0K |
| YoY Change | -16.78% | -68.75% |
| Operating Profit | -$738.2K | -$887.0K |
| YoY Change | -16.78% | -68.75% |
| Interest Expense | $967.3K | -$1.027M |
| YoY Change | -194.22% | 9.11% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $2.645M | |
| YoY Change | ||
| Pretax Income | $3.586M | $1.589M |
| YoY Change | 125.73% | -146.77% |
| Income Tax | $0.00 | |
| % Of Pretax Income | 0.0% | |
| Net Earnings | $3.586M | $1.589M |
| YoY Change | 125.73% | -146.77% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | $7.43 | |
| Diluted Earnings Per Share | $381.7K | $3.334M |
| COMMON SHARES | ||
| Basic Shares Outstanding | 482.8K shares | |
| Diluted Shares Outstanding | 9.394M shares |
Balance Sheet
| Concept | 2021 | 2020 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $3.139M | $9.970K |
| YoY Change | 31383.35% | 102.23% |
| Cash & Equivalents | ||
| Short-Term Investments | $2.645M | |
| Other Short-Term Assets | ||
| YoY Change | ||
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $3.139M | $9.970K |
| YoY Change | 31383.35% | 102.23% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $0.00 | |
| YoY Change | -100.0% | |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $0.00 | $200.00 |
| YoY Change | -100.0% | 0.0% |
| Total Long-Term Assets | $0.00 | $200.00 |
| YoY Change | -100.0% | -77.53% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $3.139M | $9.970K |
| Total Long-Term Assets | $0.00 | $200.00 |
| Total Assets | $3.139M | $10.17K |
| YoY Change | 30764.21% | 74.74% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $2.185M | $2.563M |
| YoY Change | -14.74% | -3.52% |
| Accrued Expenses | $4.225M | $4.484M |
| YoY Change | -5.77% | -4.5% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $3.962M | $3.376M |
| YoY Change | 17.34% | -39.12% |
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $11.09M | $11.68M |
| YoY Change | -5.05% | -14.73% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $0.00 | $0.00 |
| YoY Change | ||
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $11.09M | $11.68M |
| Total Long-Term Liabilities | $0.00 | $0.00 |
| Total Liabilities | $11.09M | $11.68M |
| YoY Change | -5.05% | -14.73% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$7.948M | -$11.67M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $3.139M | $10.17K |
| YoY Change | 30764.21% | 74.74% |
Cashflow Statement
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q4 | us-gaap |
Deposits Assets
DepositsAssets
|
USD | |
| CY2020Q4 | IMUN |
Undocumented Investor Advances Current
UndocumentedInvestorAdvancesCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
| CY2020 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
USD | |
| CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
| CY2020 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
USD | |
| CY2021 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
| CY2020 | us-gaap |
Gross Profit
GrossProfit
|
USD | |
| CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
USD | |
| CY2020 | IMUN |
Receipt Of Common Shares
ReceiptOfCommonShares
|
USD | |
| CY2020 | IMUN |
Change In Market Value Of Common Shares
ChangeInMarketValueOfCommonShares
|
USD | |
| CY2021 | IMUN |
Financecharges
Financecharges
|
USD | |
| CY2021 | IMUN |
Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
|
USD | |
| CY2020 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
USD | |
| CY2020 | IMUN |
Change In Market Value Of Equity Securities
ChangeInMarketValueOfEquitySecurities
|
USD | |
| CY2021 | IMUN |
Noncash Finance Charge
NoncashFinanceCharge
|
USD | |
| CY2021 | us-gaap |
Depreciation
Depreciation
|
USD | |
| CY2020 | IMUN |
Increase Decrease In Deposit
IncreaseDecreaseInDeposit
|
USD | |
| CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
USD | |
| CY2020 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
USD | |
| CY2021 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
USD | |
| CY2020 | IMUN |
Reclassification To Notes Payable From Accrued Interest
ReclassificationToNotesPayableFromAccruedInterest
|
USD | |
| CY2021 | IMUN |
Debt Discounts On Notes Payable And Warrants
DebtDiscountsOnNotesPayableAndWarrants
|
USD | |
| CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
USD | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
shares | |
| CY2020 | IMUN |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodExercisePrice
|
||
| CY2020 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAveragePrice
|
||
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
| CY2020 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodExercisePrice
|
||
| CY2020 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAveragePrice
|
||
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
shares | |
| CY2021 | IMUN |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodExercisePrice
|
||
| CY2021 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAveragePrice
|
||
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
shares | |
| CY2020 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodExercisePrice
|
||
| CY2021 | IMUN |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAveragePrice
|
||
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
USD | |
| CY2021Q4 | IMUN |
Deferred Tax Assets Capitalization Of Startup Costs For Tax Purposes
DeferredTaxAssetsCapitalizationOfStartupCostsForTaxPurposes
|
USD | |
| CY2021Q4 | IMUN |
Deferred Tax Assets Loss On Debt Conversion Of Debt
DeferredTaxAssetsLossOnDebtConversionOfDebt
|
0 | USD |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
USD | |
| CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
| CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure |
